content: UNITED STATES
  
                          SECURITIES AND EXCHANGE COMMISSION
  
                                WASHINGTON, D.C. 20549
  
                                       FORM 8-K
  
                                    CURRENT REPORT
  
  
  
  
  
  
          Pursuant to Section 13 OR  15(d)  of The Securities Exchange Act of
          1934
  
  
          Date of Report (Date of earliest event reported) March 14, 1995.
  
  
  
  
                             MAXICARE HEALTH PLANS, INC.                     
          -------------------------------------------------------------------
                 (Exact name of registrant as specified in its charter)
  
  
  
  
                   Delaware                0-12024           95-3615709      
          -------------------------------------------------------------------
  
  
          (Name or other jurisdiction    (Commission      (IRS Employer
              of incorporation)          File Number)     Identification No.)
  
  
  
  
            1149 South Broadway Street, Los Angeles, California    90015     
          -------------------------------------------------------------------
            (Address of principal executive offices)             (Zip Code)
  
  
  
  
          Registrant's telephone number, including area code  (213) 765-2000 
                                                             ----------------
  
  
  
  
                                        1 of 3
          <PAGE>
          Item 5.  Other Events
  
                   Maxicare Health Plans, Inc.  (the "Company") concluded the
                   redemption  of   its   Series   A  Cumulative  Convertible
                   Preferred Stock ("Series A Stock")  on March 14, 1995 (the
                   "Redemption Date").  Holders of approximately 2.27 million
                   shares of  Series  A  Stock  converted  their  shares into
                   approximately 6.25 million shares  of the Company's Common
                   Stock.  After  the  Redemption  Date, the remaining 21,000
                   shares of  Series  A  Stock  are  no  longer  deemed to be
                   outstanding and holders of Series A Stock certificates are
                   entitled  to  receive  only   $25.4625  per  share,  which
                   represents the redemption price  of  $25.00 per share plus
                   accrued and unpaid dividends  of $.4625 per share, without
                   additional interest thereon when they surrender the Series
                   A Stock Share  certificates  properly endorsed to American
                   Stock Transfer & Trust Company, the Redemption Agent. 
  
                   As of March 14, 1995,  the Company had approximately 17.30
                   million shares of Common Stock outstanding.
  
  
  
  
  
  
  
  
  
  
  
  
  
  
                                        2 of 3
          <PAGE>
                                      SIGNATURES
  
  
  
  
               Pursuant to the requirements of the Securities Exchange Act of
          1934, the registrant has duly  caused  this  report to be signed on
          its behalf by the undersigned thereunto duly authorized.
  
  
  
  
                                        Maxicare Health Plans, Inc.
                                        ---------------------------------
                                              (Registrant)
  
  
          March 14, 1995                By  /s/ EUGENE L. FROELICH       
                                        ---------------------------------
                                                Eugene L. Froelich
                                             Chief Financial Officer
                                           and Executive Vice President -
                                           Finance and Administration
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
                                        3 of 3
metadata_documents: [{"type": "8-K", "sequence": "1", "description": "FORM 8-K", "secsgml_size_bytes": 3713}]
metadata_filer: {"company-data": {"conformed-name": "MAXICARE HEALTH PLANS INC", "cik": "0000722573", "assigned-sic": "6324", "irs-number": "953615709", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-12024", "film-number": "95520724"}, "business-address": {"street1": "1149 S BROADWAY ST", "street2": "SUITE 910", "city": "LOS ANGELES", "state": "CA", "zip": "90015", "phone": "2137652000"}}
text: UNITED STATES
  
                          SECURITIES AND EXCHANGE COMMISSION
  
                                WASHINGTON, D.C. 20549
  
                                       FORM 8-K
  
                                    CURRENT REPORT
  
          Pursuant to Section 13 OR  15(d)  of The Securities Exchange Act of
          1934
  
          Date of Report (Date of earliest event reported) March 14, 1995.
  
                             MAXICARE HEALTH PLANS, INC.                     
          -------------------------------------------------------------------
                 (Exact name of registrant as specified in its charter)
  
                   Delaware                0-12024           95-3615709      
          -------------------------------------------------------------------
  
          (Name or other jurisdiction    (Commission      (IRS Employer
              of incorporation)          File Number)     Identification No.)
  
            1149 South Broadway Street, Los Angeles, California    90015     
          -------------------------------------------------------------------
            (Address of principal executive offices)             (Zip Code)
  
          Registrant's telephone number, including area code  (213) 765-2000 
                                                             ----------------
  
                                        1 of 3
  Item 5.  Other Events
  
                   Maxicare Health Plans, Inc.  (the "Company") concluded the
                   redemption  of   its   Series   A  Cumulative  Convertible
                   Preferred Stock ("Series A Stock")  on March 14, 1995 (the
                   "Redemption Date").  Holders of approximately 2.27 million
                   shares of  Series  A  Stock  converted  their  shares into
                   approximately 6.25 million shares  of the Company's Common
                   Stock.  After  the  Redemption  Date, the remaining 21,000
                   shares of  Series  A  Stock  are  no  longer  deemed to be
                   outstanding and holders of Series A Stock certificates are
                   entitled  to  receive  only   $25.4625  per  share,  which
                   represents the redemption price  of  $25.00 per share plus
                   accrued and unpaid dividends  of $.4625 per share, without
                   additional interest thereon when they surrender the Series
                   A Stock Share  certificates  properly endorsed to American
                   Stock Transfer & Trust Company, the Redemption Agent. 
  
                   As of March 14, 1995,  the Company had approximately 17.30
                   million shares of Common Stock outstanding.
  
                                        2 of 3
  SIGNATURES
  
               Pursuant to the requirements of the Securities Exchange Act of
          1934, the registrant has duly  caused  this  report to be signed on
          its behalf by the undersigned thereunto duly authorized.
  
                                        Maxicare Health Plans, Inc.
                                        ---------------------------------
                                              (Registrant)
  
          March 14, 1995                By  /s/ EUGENE L. FROELICH       
                                        ---------------------------------
                                                Eugene L. Froelich
                                             Chief Financial Officer
                                           and Executive Vice President -
                                           Finance and Administration
  
                                        3 of 3